Compile Data Set for Download or QSAR
Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 8070
TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232262(US9345742, 20)
Affinity DataIC50: 1nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232279(US9345742, 37)
Affinity DataIC50: 3.20nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232284(US9345742, 42)
Affinity DataIC50: 3.60nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232270(US9345742, 28)
Affinity DataIC50: 3.70nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232261(US9345742, 19)
Affinity DataIC50: 3.90nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232275(US9345742, 33)
Affinity DataIC50: 4.10nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232252(US9345742, 10)
Affinity DataIC50: 5.10nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232257(US9345742, 15)
Affinity DataIC50: 5.70nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232276(US9345742, 34)
Affinity DataIC50: 6.20nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232281(US9345742, 39)
Affinity DataIC50: 9.90nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232274(US9345742, 32)
Affinity DataIC50: 12nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232249(US9345742, 7)
Affinity DataIC50: 18nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232264(US9345742, 22)
Affinity DataIC50: 27nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232278(US9345742, 36)
Affinity DataIC50: 28nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232258(US9345742, 16)
Affinity DataIC50: 36nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232286(US9345742, 44)
Affinity DataIC50: 39nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232243(US9345742, 1)
Affinity DataIC50: 40nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232269(US9345742, 27)
Affinity DataIC50: 46nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232255(US9345742, 13)
Affinity DataIC50: 47nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232265(US9345742, 23)
Affinity DataIC50: 50nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232251(US9345742, 9)
Affinity DataIC50: 81nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232263(US9345742, 21)
Affinity DataIC50: 81nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232246(US9345742, 4)
Affinity DataIC50: 97nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232254(US9345742, 12)
Affinity DataIC50: 110nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232273(US9345742, 31)
Affinity DataIC50: 120nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232256(US9345742, 14)
Affinity DataIC50: 160nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232271(US9345742, 29)
Affinity DataIC50: 180nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232277(US9345742, 35)
Affinity DataIC50: 190nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232250(US9345742, 8)
Affinity DataIC50: 200nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232280(US9345742, 38)
Affinity DataIC50: 230nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232285(US9345742, 43)
Affinity DataIC50: 240nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232266(US9345742, 24)
Affinity DataIC50: 240nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232287(US9345742, 45)
Affinity DataIC50: 280nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232272(US9345742, 30)
Affinity DataIC50: 400nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232283(US9345742, 41)
Affinity DataIC50: 480nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232267(US9345742, 25)
Affinity DataIC50: 520nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232253(US9345742, 11)
Affinity DataIC50: 610nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232282(US9345742, 40)
Affinity DataIC50: 800nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232248(US9345742, 6)
Affinity DataIC50: 1.20E+3nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232247(US9345742, 5)
Affinity DataIC50: 1.80E+3nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232244(US9345742, 2)
Affinity DataIC50: 2.00E+3nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM232245(US9345742, 3)
Affinity DataIC50: 5.50E+3nMpH: 5.5 T: 2°CAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent